Ameritas Investment Partners, Inc. - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$6,564
-37.0%
2,8540.0%0.00%
Q2 2023$10,417
-13.2%
2,854
+16.5%
0.00%
Q1 2022$12,000
-57.1%
2,4500.0%0.00%
-100.0%
Q4 2021$28,000
-22.2%
2,4500.0%0.00%0.0%
Q3 2021$36,000
+24.1%
2,4500.0%0.00%0.0%
Q2 2021$29,000
-3.3%
2,4500.0%0.00%0.0%
Q1 2021$30,000
-3.2%
2,4500.0%0.00%0.0%
Q4 2020$31,000
-16.2%
2,4500.0%0.00%
-50.0%
Q3 2020$37,000
-38.3%
2,4500.0%0.00%
-33.3%
Q2 2020$60,000
+172.7%
2,450
+55.5%
0.00%
+200.0%
Q1 2020$22,000
-12.0%
1,5760.0%0.00%0.0%
Q4 2019$25,000
+92.3%
1,5760.0%0.00%0.0%
Q3 2019$13,000
-7.1%
1,5760.0%0.00%0.0%
Q2 2019$14,000
+16.7%
1,5760.0%0.00%0.0%
Q1 2019$12,000
+71.4%
1,5760.0%0.00%
Q4 2018$7,000
-50.0%
1,5760.0%0.00%
-100.0%
Q3 2018$14,000
-26.3%
1,5760.0%0.00%0.0%
Q2 2018$19,000
+72.7%
1,576
+109.6%
0.00%0.0%
Q1 2018$11,0007520.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,915,219$23,959,0005.70%
Prosight Management, LP 906,569$11,341,0005.24%
P.A.W. CAPITAL CORP 140,000$1,751,0001.54%
Voss Capital, LLC 220,714$2,761,0001.39%
Robertson Stephens Wealth Management, LLC 484,000$6,054,0001.26%
Slate Path Capital LP 1,483,619$18,560,0001.00%
Nantahala Capital Management 2,506,772$31,360,0000.97%
PRECEPT MANAGEMENT LLC 150,000$1,877,0000.76%
SANDERS MORRIS HARRIS LLC 193,591$2,449,0000.56%
Rock Creek Group, LP 100,014$1,251,0000.51%
View complete list of CUE BIOPHARMA INC shareholders